Xolair Logo
Dec. 25, 2024
Alvotech Enters Exclusive Global Licensing Agreement with BiosanaPharma for Co-Development of a Proposed Biosimilar (AVT23) to Xolair® (Omalizumab) | Business Wire FDA accepts application for self-administered Xolair use - PharmaTimes Genentech wins FDA approval for Xolair prefilled syringe - Drug Delivery Business Xolair Logo